Home
/ Kancera
/ Competitors

Kancera Competitors and Similar CompaniesClear all

Kancera's competitors and similar companies include A2 Biotherapeutics, Clasp Therapeutics and Gamida Cell.

	Kancera Kancera is a company that develops drugs against inflammatory diseases and cancer.	A2 Biotherapeutics A2 Biotherapeutics is a biotechnology company that develops cell therapies for cancer patients.	Clasp Therapeutics Clasp Therapeutics is a company that provides immuno-oncology solutions.	Gamida Cell Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases.
Founding Date	Founding Date 2010	Founding Date 2018	Founding Date 2020	Founding Date 1998
Type	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech oncology	Tags Healthcare biotech oncology	Tags Healthcare biotech oncology	Tags Healthcare biotech oncology
Locations	Locations Solna, SE HQ Solna, SE	Locations Agoura Hills, US HQ	Locations Rockville, US HQ Cambridge, US	Locations Boston, US HQ Jerusalem, IL
Employees	Employees 5	Employees 1255% decrease	Employees 502% increase	Employees 143175% increase
Valuation ($)	Valuation ($) 19.4 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 4.3 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $1.8m (FY, 2023)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $1.5m (FY, 2023)
Gross profit	Gross profit kr14k (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit $330k (FY, 2023)
Net income	Net income (kr47.2m) (FY, 2025)	Net income N/A	Net income N/A	Net income ($63m) (FY, 2023)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 71.5m (over 5 years ago)	Latest funding round $ 150m (about 2 years ago)	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised $ 128.5m	Total funding raised $ 150m	Total funding raised $ 128.3m